BTIG Maintains Buy on OrthoPediatrics, Raises Price Target to $29

Benzinga Newsdesk www.benzinga.com Positive 71.4%

Neg 0% Neu 0% Pos 71.4%

BTIG analyst Ryan Zimmerman maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and raises the price target from $24 to $29.